Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide...

Details Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide... Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide...

2006-03-17

2009-11-24

Kumar, Shailendra (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S268100, C546S276400, C546S336000, C514S318000, C514S352000, C514S357000

Reexamination Certificate

active

07622589

ABSTRACT:
This invention provides a compound of the formula (I):wherein, variables A, B, D, E, and R1to R11are as defined in the specification.

REFERENCES:
patent: 4681952 (1987-07-01), Lantzsch et al.
patent: 4786646 (1988-11-01), Guthrie et al.
patent: 4927826 (1990-05-01), Guthrie et al.
patent: 4988734 (1991-01-01), Kraatz et al.
patent: 5082852 (1992-01-01), Kardorff et al.
patent: 5286736 (1994-02-01), Soyka et al.
patent: 5633239 (1997-05-01), Englert et al.
patent: 2003/0153596 (2003-08-01), Suh et al.
patent: 2004/0110754 (2004-06-01), Wu et al.
patent: 2004/0204341 (2004-10-01), Allen et al.
patent: 2005/0004122 (2005-01-01), Brown et al.
patent: 1314563 (1993-03-01), None
patent: 1108213 (1961-06-01), None
patent: 102005011056 (2005-10-01), None
patent: 1086191 (1967-10-01), None
patent: 1086192 (1967-10-01), None
patent: 56-005435 (1981-01-01), None
patent: 8245555 (1996-09-01), None
patent: 2005-314407 (2005-11-01), None
patent: 2293080 (2004-07-01), None
patent: WO9406761 (1994-03-01), None
patent: WO9427947 (1994-12-01), None
patent: WO9748397 (1997-12-01), None
patent: WO9748695 (1997-12-01), None
patent: WO9926927 (1999-06-01), None
patent: WO9931060 (1999-06-01), None
patent: WO9931064 (1999-06-01), None
patent: WO0021910 (2000-04-01), None
patent: WO0111966 (2001-02-01), None
patent: WO0155146 (2001-08-01), None
patent: WO0202522 (2002-01-01), None
patent: WO 02/16318 (2002-02-01), None
patent: WO03082190 (2003-10-01), None
patent: WO 2004/047738 (2004-06-01), None
patent: WO2004108133 (2004-12-01), None
patent: WO 2005/003084 (2005-01-01), None
patent: WO 2005/007614 (2005-01-01), None
patent: WO2005051890 (2005-06-01), None
patent: WO2005068468 (2005-07-01), None
patent: WO2006098554 (2006-09-01), None
Hee-Doo Kim, et al., “Chain-branched 1, 3-dibenzylthioureas as Vanilloid Receptor 1 Antagonists”, Bioorganic Medicinal Chemistry Letters, 2004, pp. 1751-1755, vol. 14, No. 7.
Jeewoo Lee, et al., “N-(3-Acyloxy-2-benzylpropy1)-N′-[4-(methylsulfonylamino)benzyl]thiourea Analogues: Novel Potent and High Affinity Antagonists and Partial Antagonists of the Vanilloid Receptor”, J Med Chem, 2003, pp. 3116-3126, vol. 46, No. 14.
Jeewoo Lee, et al., 'Analysis of Structure-activity Relationships with the N-(3-Acyloxy-2-benzylpropyl)-N′-[4-(methylsulfonylamino)benzyl]thiourea Template for Vanilloid Receptor 1 Antagonism, Bioorganic & Medicinal Chemistry, 2004, p. 3411-3420, vol. 12, No. 13.
“Rodriques et al: ““A Novel route toCycloPropyl Ketones, Aldehydes, andCarboxylic acids””, Tetrahedron Letters, 1991, pp. 1275-1278, vol. 32, No. 10”.
Young-Ger Suh, et al., “Novel non-Vanilloid VR1 Antagonis of High Analgesic Effects and its Structural Requirement for VR1 Antagonistic Effects”, Bioorganic & Medicinal Chemistry Letters, 2003, pp. 4389-4398, vol. 13, No. 24.
“Susanna Tchilibon, et al., ““ExploringDistal Regions of the A3 AdenosineReceptor Binding Site: StericallyConstrained N6-(2-phenylethyl)adenosineDerivatives as Potent Ligands””, Bioorganic & Medicinal Chemistry, 2004, pp. 2021-2034, vol. 12, No. 9”.
PCT International Search Report for PCT/IB2006/000557 Dated Jul. 5, 2006.
Dutch Industrial Property Office Search Report for Application No. 1031385, Dated Aug. 30, 2006.
C. Deal, et al., “Treatment of Arthritis with Topical Capsaicin:Double-Blind Trial”, Clin Ther, 1991, pp. 383-395, vol. 13, No. 3.
J. Fernihough, et al, “Regulation of Calcitonin Gene-related Peptide and TRPV1 in a Rat Model of Osteoarthritis”, Neuroscience Letters, Nov. 2005, pp. 75-80, vol. 388, No. 2.
P. Honore, et al., “A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats”, J Pharmacol Exp Ther, 2005, pp. 410-421, vol. 314 No. 1.
R. Planells-Cases, et al., Functional Aspects and Mechanisms of TRPV1 Involvement in Neurogenic Inflammation that Leads to Thermal Hyperalgesia, Eur J Physiol, 2005, pp. 151-159, vol. 451.

Affiliated with

Also associated with

Rating

Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4093218